LI Wen-yu, HUANG Ling. Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients[J]. Journal of Evidence-Based Medicine, 2014, 14(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2014.02.009
|
Citation:
|
LI Wen-yu, HUANG Ling. Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients[J]. Journal of Evidence-Based Medicine, 2014, 14(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2014.02.009
|
LI Wen-yu, HUANG Ling. Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients[J]. Journal of Evidence-Based Medicine, 2014, 14(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2014.02.009
|
Citation:
|
LI Wen-yu, HUANG Ling. Long-Term Efficacy and Safety of BEACOPP Escalated-Dose in Advanced Stage Hodgkin Lymphoma Patients[J]. Journal of Evidence-Based Medicine, 2014, 14(2): 74-76. DOI: 10.3969/j.issn.1671-5144.2014.02.009
|
DownLoad: